Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ONCO.ST - Oncopeptides AB
Q1 2025 Oncopeptides AB Earnings Call
May 15, 2025 / 07:00AM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi, everyone, and welcome to the presentation of Oncopeptide's report for the first quarter of 2025. This is our standard disclaimer.
I'm Sophia Reiss, CEO of Oncoeptides, and I'm joined as always by our CFO Hendrik Bentoft who will walk you through the financials.
But let's begin by highlighting some key developments this quarter.
The first quarter was a strong start to the year, despite some headwinds in terms of weaker EUR which we sell in compared to the SEK which we report in and some seasonal effects that temporarily postponed treatments for certain patients, we delivered net sales of 13.3 million sick.
That means we almost tripled our sales compared to Q1 last year and see a 34% increase compared to
Trustpilot
